Did Felix Hoffmann really invent aspirin, or was he just a lab technician?

Did Felix Hoffmann really invent aspirin, or was he just a lab technician?
Image: Intellect (generated)

In short: Felix Hoffmann is celebrated for synthesizing aspirin and heroin while working at Bayer in the late 1890s. Yet, his legacy is shrouded in controversy. Was he a brilliant innovator who solved his father's medical pain, or did he merely execute the instructions of a supervisor who was later erased from history?

Born in 1868 in Ludwigsburg, Germany, Felix Hoffmann joined Bayer as a research chemist in 1894. By 1897, he had successfully synthesized acetylsalicylic acid (ASA) in a stable, pure form. This breakthrough provided a vital alternative to sodium salicylate, a treatment for rheumatism that required high doses and frequently caused severe stomach irritation. By 1899, Bayer began marketing this compound as Aspirin, eventually cementing Hoffmann’s reputation as a pioneer of modern pharmaceuticals.

However, the narrative of his singular genius is heavily contested. In 1934, Hoffmann claimed he pursued the synthesis independently to help his father, who suffered from the bitter taste and side effects of existing treatments. This story remained the standard account for decades, leading to his 2002 induction into the US National Inventors Hall of Fame. Yet, an alternative history emerged in 1949 when Arthur Eichengrün, Hoffmann’s former supervisor at Bayer, published a paper asserting that he had planned the entire process, directed the synthesis, and managed the initial clinical trials.

For years, Eichengrün’s claims were largely ignored. The academic consensus shifted in 1999 when Walter Sneader of the University of Strathclyde re-examined the evidence and concluded that Eichengrün was the true architect of the invention. Despite this, Bayer continues to officially attribute the discovery to Hoffmann. Beyond aspirin, Hoffmann also synthesized diamorphine—later marketed as heroin—which was initially used to treat everything from childhood coughs to morphine addiction, before its own devastating addictive properties became clear. Hoffmann eventually moved into marketing, retiring in 1928 and dying in Switzerland in 1946.

The dispute highlights how corporate history can obscure individual contributions. While Hoffmann’s laboratory work was undeniably effective, the question of whether he was the primary inventor or a skilled subordinate remains a point of contention between historians and the company that holds the patent legacy. Whether the credit belongs to the man who performed the synthesis or the man who designed the process remains a subject of ongoing debate in the history of chemistry.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/technology-felix-hoffmann.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…